Results 21 to 30 of about 2,565,077 (232)
Saudi Journal of Medicine and Medical Sciences, 2023 Background: Prostate cancer screening with prostate-specific antigen (PSA) can result in unnecessary biopsies and overdiagnosis. Alternately, PSA density (PSAD) calculation may help support biopsy decisions; however, evidence of its usefulness is not ...
Mostafa A Arafa +5 more
doaj +1 more source
Prostate International, 2019 Background: Prostate-specific antigen (PSA)–based screening for prostate cancer has been widely performed, but its accuracy is unsatisfactory. To improve accuracy, building an effective statistical model using machine learning methods (MLMs) is a ...
Satoshi Nitta +8 more
doaj +1 more source
Identifying Prostate Cancer Among Men with Lower Urinary Tract Symptoms
European Urology Open Science, 2021 Background: In men aged above 50 yr, lower urinary tract symptoms (LUTS), benign prostate hyperplasia, and prostate cancer are common urological conditions. Current guidelines for general practitioners frequently recommend prostate-specific antigen (PSA)
Tobias Nordström +7 more
doaj +1 more source
European Urology Open Science, 2021 Prostate-specific antigen (PSA) density is an established prognostic marker for prostate cancer. We investigated whether the inclusion of PSA density or prostate volume in the Memorial Sloan Kettering Cancer Center nomograms improves the prediction of ...
Michael Tzeng +7 more
doaj +1 more source
CUT-OFF POINT OF PSA AND PSA DENSITY IN PROSTATE CANCER SUSPECTED PATIENTS
Jurnal Urologi Indonesia, 2016 Objective: In Hasan Sadikin General Hospital Bandung prostate biopsy is recommended for patients with prostate specific antigen (PSA) levels above 10 ng/mL or PSA density (PSAD) above 0.15 if PSA in between 4–10 ng/mL.
Daniel Simanjuntak, Ferry Safriadi
doaj +1 more source
THE VALUE OF TRANSITIONAL ZONE PSA DENSITY IN THE DIAGNOSİS OF THE PROSTATIC CARCINOMA
Urology Research and Practice, 2019 PSA is the most important tumor marker for the diagnosis of prostatic carcinoma. If 4.0 ng/ml, which is the widely accepted cut-off value, is used, 2/3 of the biopsies are negative.
C. Sönmez +5 more
doaj +2 more sources
Reliability of volume or age-adjusted prostate specific antigen to improve diagnostic accuracy
The International Journal of Biological Markers, 1995 Prostate Specific Antigen (PSA), PSA density, PSA excess, and PSA age-specific range have been compared in 331 subjects (35 cancers, 296 benign) with equivocal findings at screening by PSA or palpation + transrectal ultrasonography.
S. Ciatto +3 more
doaj +1 more source
Performance of PSA and of PSA density in the diagnosis of prostate carcinoma
Acta Cirúrgica Brasileira, 2002 OBJECTIVE: The aim of the study was to investigate the influence of the prostate volume and PSA density on the performance of total PSA to diagnosis of prostate carcinoma. METHODS: We analyzed 217 patients (PSA 0-10ng/ml) submitted to transrectal sextant
Antonio Carlos Pereira Martins +5 more
doaj +1 more source
Characterisation of an automated Dual Piston Pressure Swing Adsorption (DP-PSA) system [PDF]
, 2013 The drive to fast Pressure Swing Adsorption (PSA) processes leads to the challenge of designing and analysing experiments that allow the testing of adsorbents under fast cycle conditions. Here we present the Dual Piston-Pressure Swing Adsorption (DP-PSA)
Brandani, Stefano +2 more
core +1 more source
Advanced Biomedical Research, 2016 Background: Prostate cancer is one of the most common male cancers. The prevalence of prostate cancer is different due to genetic and environmental factors.
Farhad Tadayon +5 more
doaj +1 more source